Advertisement

Topics

Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial

2016-11-07 08:56:11 | BioPortfolio

Published on BioPortfolio: 2016-11-07T08:56:11-0500

Clinical Trials [503 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Short Term Use of Experimental Eye Drops BHVI2, 0.02% Atropine and BHVI2 Plus 0.02% Atropine Eye Drops

To assess the one-month ocular effects of nightly application of experimental BHVI2 and 0.02% atropine eye drops either alone or in combination, in children aged between 6 to 13 years old ...

Effects of Low Concentration Atropine on Pupillary Size and Accommodative Amplitude

To assess the two-week ocular responses, especially on pupillary size and accommodative amplitude, of nightly application of 0.01% or 0.02% or 0.03% atropine eye drops in children with myo...

Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children

The purpose of this study is to find an optimal dose of atropine for preventing the rapid progression of myopia in children by comparing the efficacy, safety and functional impact of binoc...

Eye Drops Study for Myopia Control in Schoolchildren

The myopia prevalence in schoolchildren is high in Taiwan. The myopia progression is fast in children and often associated high myopia in later life. This prospective and randomized study ...

The Effects of Low Concentration Atropine on Pupil Size and Accommodation

The purpose of this study is to determine whether less frequent dosing of atropine drops may be as effective as daily dosing for the treatment of progressive myopia.

PubMed Articles [407 Associated PubMed Articles listed on BioPortfolio]

Myopia and orthokeratology for myopia control.

The prevalence of myopia in children is increasing worldwide and is viewed as a major public health concern. This increase has driven interest in research into myopia prevention and control in childre...

Alpha -adrenoceptor agonists inhibit form-deprivation myopia in the chick.

The putative myopia-controlling receptor is thought to be muscarinic acetylcholine receptor subtype M , because mamba toxin-3 can inhibit form-deprivation myopia in chicks at a far lower concentration...

Effects of time-of-day on inhibition of lens-induced myopia by quinpirole, pirenzepine and atropine in chicks.

Injections of the D2 dopamine receptor agonist quinpirole or the acetylcholine muscarinic receptor antagonists pirenzepine and atropine prevent the development of negative-lens-induced myopia in chick...

IMI - Myopia Control Reports Overview and Introduction.

With the growing prevalence of myopia, already at epidemic levels in some countries, there is an urgent need for new management approaches. However, with the increasing number of research publications...

Controlling Progression of Myopia: Optical and Pharmaceutical Strategies.

The burden associated with the rising prevalence of myopia and high myopia, and the associated vision impairment and sight-threatening complications, has triggered the need to evaluate strategies to c...

Medical and Biotech [MESH] Definitions

The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from irrigation in that the irrigate is removed within minutes, but the instillate is left in place.

A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of ATROPINE. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect.

Excessive axial myopia associated with complications (especially posterior staphyloma and CHOROIDAL NEOVASCULARIZATION) that can lead to BLINDNESS.

One ring heterocyclic compounds defined by C6H7NO. Permitted are any degree of hydrogenation, any substituents and any ortho-fused or ortho-peri-fused ring systems.

Analogs and derivatives of atropine.

More From BioPortfolio on "Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial